155 related articles for article (PubMed ID: 34796791)
1. Immuno-informatics guided designing of a multi-epitope vaccine against Dengue and Zika.
Bhardwaj A; Sharma R; Grover A
J Biomol Struct Dyn; 2023 Jan; 41(1):1-15. PubMed ID: 34796791
[TBL] [Abstract][Full Text] [Related]
2. Blueprint of epitope-based multivalent and multipathogenic vaccines: targeted against the dengue and zika viruses.
Sarkar B; Ullah MA; Araf Y; Das S; Hosen MJ
J Biomol Struct Dyn; 2021 Nov; 39(18):6882-6902. PubMed ID: 32772811
[TBL] [Abstract][Full Text] [Related]
3. Design of a multi-epitope Zika virus vaccine candidate - an
Ezzemani W; Windisch MP; Altawalah H; Guessous F; Saile R; Benjelloun S; Kettani A; Ezzikouri S
J Biomol Struct Dyn; 2023 Jun; 41(9):3762-3771. PubMed ID: 35318896
[TBL] [Abstract][Full Text] [Related]
4. Rational design of B-cell and T-cell multi epitope-based vaccine against Zika virus, an
Ganji M; Bakhshi S; Ahmadi K; Shoari A; Moeini S; Ghaemi A
J Biomol Struct Dyn; 2024 Apr; 42(7):3426-3440. PubMed ID: 37190978
[TBL] [Abstract][Full Text] [Related]
5. Immunoinformatics guided rational design of a next generation multi epitope based peptide (MEBP) vaccine by exploring Zika virus proteome.
Shahid F; Ashfaq UA; Javaid A; Khalid H
Infect Genet Evol; 2020 Jun; 80():104199. PubMed ID: 31962160
[TBL] [Abstract][Full Text] [Related]
6. Exploring dengue proteome to design an effective epitope-based vaccine against dengue virus.
Sabetian S; Nezafat N; Dorosti H; Zarei M; Ghasemi Y
J Biomol Struct Dyn; 2019 Jul; 37(10):2546-2563. PubMed ID: 30035699
[TBL] [Abstract][Full Text] [Related]
7. Linear epitope mapping in the E and NS1 proteins of dengue and Zika viruses: Prospection of peptides for vaccines and diagnostics.
Aquino VH; Fumagalli MJ; Silva A; de Moura Negrini BV; Rojas A; Guillen Y; Bernal C; Figueiredo LTM
PLoS One; 2023; 18(10):e0292451. PubMed ID: 37788262
[TBL] [Abstract][Full Text] [Related]
8. In silico design of a Zika virus non-structural protein 5 aiming vaccine protection against zika and dengue in different human populations.
Dos Santos Franco L; Oliveira Vidal P; Amorim JH
J Biomed Sci; 2017 Nov; 24(1):88. PubMed ID: 29169357
[TBL] [Abstract][Full Text] [Related]
9. Immune Response to Dengue and Zika.
Ngono AE; Shresta S
Annu Rev Immunol; 2018 Apr; 36():279-308. PubMed ID: 29345964
[TBL] [Abstract][Full Text] [Related]
10. Pre-existing T Cell Memory against Zika Virus.
Schouest B; Grifoni A; Pham J; Mateus J; Sydney J; Brien JD; De Silva AD; Balmaseda A; Harris E; Sette A; Weiskopf D
J Virol; 2021 May; 95(12):. PubMed ID: 33789994
[TBL] [Abstract][Full Text] [Related]
11. Recombination of B- and T-cell epitope-rich loci from Aedes- and Culex-borne flaviviruses shapes Zika virus epidemiology.
Gaunt MW; Gubler DJ; Pettersson JH; Kuno G; Wilder-Smith A; de Lamballerie X; Gould EA; Falconar AK
Antiviral Res; 2020 Feb; 174():104676. PubMed ID: 31837392
[TBL] [Abstract][Full Text] [Related]
12. Immuno-informatics-based Identification of Novel Potential B Cell and T Cell Epitopes to Fight Zika Virus Infections.
Ezzemani W; Windisch MP; Kettani A; Altawalah H; Nourlil J; Benjelloun S; Ezzikouri S
Infect Disord Drug Targets; 2021; 21(4):572-581. PubMed ID: 32778040
[TBL] [Abstract][Full Text] [Related]
13. Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development.
Elong Ngono A; Shresta S
Front Immunol; 2019; 10():1316. PubMed ID: 31244855
[TBL] [Abstract][Full Text] [Related]
14. Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.
Swanstrom JA; Plante JA; Plante KS; Young EF; McGowan E; Gallichotte EN; Widman DG; Heise MT; de Silva AM; Baric RS
mBio; 2016 Jul; 7(4):. PubMed ID: 27435464
[TBL] [Abstract][Full Text] [Related]
15. Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models.
Shukla R; Beesetti H; Brown JA; Ahuja R; Ramasamy V; Shanmugam RK; Poddar A; Batra G; Krammer F; Lim JK; Kale S; Lal AA; Swaminathan S; Khanna N
EBioMedicine; 2020 Oct; 60():102991. PubMed ID: 32949997
[TBL] [Abstract][Full Text] [Related]
16. From ZikV genome to vaccine: in silico approach for the epitope-based peptide vaccine against Zika virus envelope glycoprotein.
Alam A; Ali S; Ahamad S; Malik MZ; Ishrat R
Immunology; 2016 Dec; 149(4):386-399. PubMed ID: 27485738
[TBL] [Abstract][Full Text] [Related]
17. Designing B- and T-cell multi-epitope based subunit vaccine using immunoinformatics approach to control Zika virus infection.
Kumar Pandey R; Ojha R; Mishra A; Kumar Prajapati V
J Cell Biochem; 2018 Sep; 119(9):7631-7642. PubMed ID: 29900580
[TBL] [Abstract][Full Text] [Related]
18. Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans.
Grifoni A; Pham J; Sidney J; O'Rourke PH; Paul S; Peters B; Martini SR; de Silva AD; Ricciardi MJ; Magnani DM; Silveira CGT; Maestri A; Costa PR; de-Oliveira-Pinto LM; de Azeredo EL; Damasco PV; Phillips E; Mallal S; de Silva AM; Collins M; Durbin A; Diehl SA; Cerpas C; Balmaseda A; Kuan G; Coloma J; Harris E; Crowe JE; Stone M; Norris PJ; Busch M; Vivanco-Cid H; Cox J; Graham BS; Ledgerwood JE; Turtle L; Solomon T; Kallas EG; Watkins DI; Weiskopf D; Sette A
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978707
[TBL] [Abstract][Full Text] [Related]
19. Immune Responses to Dengue and Zika Viruses-Guidance for T Cell Vaccine Development.
Roth C; Delgado FG; Simon-Lorière E; Sakuntabhai A
Int J Environ Res Public Health; 2018 Feb; 15(2):. PubMed ID: 29473899
[TBL] [Abstract][Full Text] [Related]
20. Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization.
Lin HH; Yang SP; Tsai MJ; Lin GC; Wu HC; Wu SC
Theranostics; 2019; 9(16):4811-4826. PubMed ID: 31367259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
